Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.234NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Z.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Z.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Z.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
V.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
V.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
V.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.22NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.36.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.22NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.282NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.282NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.282NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.131NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.131NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.131NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.274NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.274NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.274NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.25NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.25NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.25NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.235NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.235NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.235NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.65NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.65NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.65NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.45NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.45NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.45NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.165NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.165NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.165NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.258.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.258.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.258.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
V.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
V.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
V.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.149NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.149NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.149NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.413NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.413NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.413NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.258.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.258.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.258.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.9.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used